ENFN Company Profile and Key Details

Q: Who are the executives of ENFN?

Caroline MaHead of Corporation Devel.Mr. Stephen MalherbeManaging PartnerMr. Oleg MovchanChief Executive Officer & DirectorMs. Bronwen BastoneChief People OfficerMr. Daniel GromanChief Technology OfficerMatt CampobassoGen. CounselMr. Stephen P. DortonChief Financial OfficerMr. Michael BerryChief Operating OfficerMr. Brian MurphyInvestorMr. Kabir KohliMD of Managed Services Solutioning & Global Head of Client ServicesMs. Lorelei M. SkillmanChief Marketing & Communications OfficerMr. Joseph DefeoGlobal Head of Managed Services ProductionMr. Bradley HerringChief Financial OfficerMr. Dan JacobsGlobal Head of SalesMr. Jeff YoungHead of ImplementationMr. Ignatius Tochukwu NjokuHead of Investor Relations

NYSE : ENFN

Enfusion

$10.76

-0.04-0.37%

At Close 4:00 PM

Not Actively Trading

64.47

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Enfusion, Inc. (ENFN) stock declined over -0.37%, trading at $10.76 on NYSE, down from the previous close of $10.80. The stock opened at $10.76, fluctuating between $10.74 and $10.87 in the recent session.

Stock Snapshot

10.8

Prev. Close

1.02B

Market Cap

10.74

Day Low

358.6666666666667

P/E Ratio

0.03

EPS (TTM)

0.17

Cash Flow per Share

10.76

Open

94.8M

Number of Shares

10.87

Day High

48.86%

Free Float in %

0.61

Book Value

2.46M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 17, 2025	10.76	10.87	10.74	10.76	2.46M
Apr 16, 2025	10.94	10.94	10.69	10.80	746.64K
Apr 15, 2025	10.75	10.96	10.75	10.92	799.82K
Apr 14, 2025	10.98	10.98	10.74	10.81	902.12K
Apr 11, 2025	10.85	10.85	10.60	10.81	2.57M
Apr 10, 2025	10.90	10.90	10.61	10.79	1.51M
Apr 09, 2025	10.50	11.01	10.46	10.96	3.11M
Apr 08, 2025	10.74	10.93	10.41	10.48	3.46M
Apr 07, 2025	10.31	10.76	10.22	10.60	2.37M
Apr 04, 2025	10.92	10.92	10.52	10.59	2.18M
Apr 03, 2025	11.05	11.11	10.99	11.00	1.54M
Apr 02, 2025	11.08	11.17	11.07	11.14	496.44K
Apr 01, 2025	11.17	11.17	11.08	11.11	702.43K
Mar 31, 2025	11.03	11.16	11.03	11.15	742.86K
Mar 28, 2025	11.14	11.16	11.09	11.10	464.67K
Mar 27, 2025	11.18	11.20	11.13	11.14	595.84K
Mar 26, 2025	11.12	11.18	11.08	11.16	918.72K
Mar 25, 2025	11.12	11.20	11.12	11.13	869.23K
Mar 24, 2025	11.15	11.19	11.10	11.14	618.43K
Mar 21, 2025	11.07	11.13	11.07	11.10	1.2M

Contact Details

Chicago, IL 60603

United States

https://www.enfusion.com 312 253 9800

About Company

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.

Stock Peers

FICO

-6.18-0.52%

Fair Isaac Corporation$1,179.19 TYL

3.36+1.14%

Tyler Technologies, Inc.$298.84 SNOW

-7.61-3.17%

Snowflake Inc.$232.78 HUBS

1.55+0.83%

HubSpot, Inc.$187.98 CRM

-0.56-0.34%

Salesforce, Inc.$165.89 SAP

0.54+0.33%

SAP SE$164.18 PAYC

2.28+1.72%

Paycom Software, Inc.$134.52 GWRE

4.04+3.41%

Guidewire Software, Inc.$122.56 NOW

-0.93-0.90%

ServiceNow, Inc.$102.15 ML

0.65+0.76%

MoneyLion Inc.$85.90

Company Overview

Enfusion, Inc. (NYSE:ENFN) closed at $10.76 USD, losing -$0.04 (-0.37%) from the previous close of $10.80. The stock is currently mid-range between its 52-week high and low $7.83 and $11.80. With a market capitalization of about $1.02 billion, Enfusion, Inc. is classified as a small-cap and shows market-like volatility (beta ~0.93). Key stats such as the average daily volume over the past year has been around 1.17 million shares, trading with heavier-than-usual volume. Headquartered in Chicago, IL, Enfusion, Inc. operates in the Technology sector and the Software - Application industry. Led by CEO Oleg Movchan, the company employs approximately 1,143 people and listed since October 21, 2021. Enfusion, Inc. supplies cloud-based software solutions designed for the investment management sector, operating throughout the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Technical Performance

ENFN has shown mixed momentum, losing -0.28% over the past week and -1.82% over the past quarter, though year-to-date performance is up 4.47%. Short-term trend indicators are mixed aligned (SMA20 -1.6%, SMA50 -3.08%, SMA200 9.44%). The stock’s 14-day RSI is 42.68 (neutral), while the ATR of 0.23 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -8.81% below its high and over 37.42% above its low.

Valuation Metrics

Enfusion, Inc. trades at a P/E ratio of 350.83, slightly above the S&P 500 average, with a price-to-sales ratio of 5.06 and a price-to-book ratio of 13.53 reflecting a rich premium to book value. The P/FCF stands at 32.86, also above market averages. Compared to sector medians, Enfusion, Inc. P/S is trading rich, and the P/B is far lower than peers, underscoring the brand and earnings power premium investors assign to the stock.

Dividend & Fair Value

Enfusion, Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $2.57. This means the shares are trading above this model’s fair value.

Earnings & Analyst Outlook

Enfusion, Inc. generated EPS of $0.02 over the past year. Five-year average earnings growth is -23.06%. Wall Street analysts project EPS growth of 27.15% annually over the next five years. The latest quarter delivered EPS of -$0.01. The next quarter is forecast at $0.06. Next year's EPS is expected at $61.95. Enfusion, Inc. earnings surprise history is frequent misses against expectations. The quarter that ended May 08, 2025, missed forecasts by -116.67%. The prior quarter beat by -57.14%. Over the last six quarters, Apple has recorded several small beats. These include -33.33% in March 12, 2024.

Shareholding & Insider Activity

Enfusion, Inc. has 94.80 million shares outstanding. The public float is 46.32 million shares, elevated short interest at 4.61% of float. This equals 1.30 million shares. The short ratio is 1.46 days. Institutional investors hold 101.03% of the float. Insiders own 4.73%. Bernstein Bradford E holds 31.30 million shares, HILLHOUSE INVESTMENT MANAGEMENT, LTD. has 4.98 million shares and WARSHAW KIRK M has 1.95 million shares.

Financial & Profitability Overview

Over the trailing twelve months, Enfusion generated $174.54M in revenue, or $1.35 per share. Gross margin was 66.97%, operating margin 6.85%, and net profit margin 3.45%. Returns are healthy, with ROA at 5.53% and ROE at 11.23%.
On valuation metrics, Enfusion trades at a P/E of 350.83, P/S of 5.06 and P/B of 13.53. The current ratio is 3.42 and quick ratio is 3.42. Operationally, the company’s inventory turnover is 0.00 and cash conversion cycle is 53.03 days. Debt-to-equity is 0.28, supported by a cash flow-to-debt ratio of 1.71.

Quarterly Financial Highlights

For the quarter ended Dec 31, 2023, Enfusion posted revenue of $174.54M, down slightly from $150.35M in the prior quarter. Gross profit was $116.89M (margin 66.97%). Operating income was $11.95M (margin 6.8%). Net income was$6.03M (EPS $0.07).
The company ended the quarter with $35.60M in cash and short-term investments, a total debt of $15.44M, and net debt of - $20.17M. Total assets were $108.97M, with equity of $77.48M. Financials further reflected stability, with operating cash flow of $24.48M, free cash flow of $14.81M, and capital expenditures of - $9.67M.

Price Forecast & Outlook

Our AI price prediction model suggests that Enfusion, Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 3.62%, with price expected at $11.15 by May 01, 2025, within a range of $10.83 to $11.45 3-Month Outlook: Projected fall of -22.21%, reaching $8.37 by July 16, 2025, with a range of $8.08 to $8.66. 1-Year Outlook: Projected gain of 171.56%, with price at $29.22 by April 17, 2026, within a range of $26.45 to $35.85.

Key Takeaways

Enfusion, Inc. (NYSE:ENFN) shares are flat 4.47% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Enfusion, Inc. trading at a premium to the broader market with a P/E of 350.83. Analyst sentiment is mixed, with the majority of ratings in Neutral territory and a mean price target of $10.71, suggesting -0.46% downside. Our AI forecast model points to short-term strength (3.62% over two weeks), a medium-term fall (-22.21% over three months), and a longer-term gain (171.56% over one year), with expected trading ranges indicating moderate volatility.

Frequently Asked Questions

What is the current Enfusion, Inc. (ENFN) stock price?

Enfusion, Inc. (NYSE: ENFN) stock price is $10.76 in the last trading session. During the trading session, ENFN stock reached the peak price of $10.87 while $10.74 was the lowest point it dropped to. The percentage change in ENFN stock occurred in the recent session was -0.37% while the dollar amount for the price change in ENFN stock was - $0.04.

ENFN's industry and sector of operation?

The NYSE listed ENFN is part of Software - Application industry that operates in the broader Technology sector. Enfusion, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of ENFN?

Caroline Ma
Head of Corporation Devel.
Mr. Stephen Malherbe
Managing Partner
Mr. Oleg Movchan
Chief Executive Officer & Director
Ms. Bronwen Bastone
Chief People Officer
Mr. Daniel Groman
Chief Technology Officer
Matt Campobasso
Gen. Counsel
Mr. Stephen P. Dorton
Chief Financial Officer
Mr. Michael Berry
Chief Operating Officer
Mr. Brian Murphy
Investor
Mr. Kabir Kohli
MD of Managed Services Solutioning & Global Head of Client Services
Ms. Lorelei M. Skillman
Chief Marketing & Communications Officer
Mr. Joseph Defeo
Global Head of Managed Services Production
Mr. Bradley Herring
Chief Financial Officer
Mr. Dan Jacobs
Global Head of Sales
Mr. Jeff Young
Head of Implementation
Mr. Ignatius Tochukwu Njoku
Head of Investor Relations

How ENFN did perform over past 52-week?

ENFN's closing price is 37.42% higher than its 52-week low of $7.83 where as its distance from 52-week high of $11.80 is -8.81%.

How many employees does ENFN have?

Number of ENFN employees currently stands at 1,143.

Link for ENFN official website?

Official Website of ENFN is: https://www.enfusion.com

How do I contact ENFN?

ENFN could be contacted at phone 312 253 9800 and can also be accessed through its website. ENFN operates from 125 South Clark Street, Chicago, IL 60603, United States.

How many shares of ENFN are traded daily?

ENFN stock volume for the day was 2.46M shares. The average number of ENFN shares traded daily for last 3 months was 1.17M.

What is the market cap of ENFN currently?

The market value of ENFN currently stands at $1.02B with its latest stock price at $10.76 and 94.8M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	1143
Beta	0.93
Sales or Revenue	$174.54M
5Y Sales Change%	2.79%
Fiscal Year Ends	December
Sector	Technology
Industry	Software - Application

ENFN Company Profile and Key Details

Enfusion

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Shareholding & Insider Activity

Dividend & Fair Value

Key Takeaways

Price Forecast & Outlook

Company Overview

Valuation Metrics